Additionally, our cohort demonstrated that MDS patients with high expression of SETBP1 had shorter survival and faster leukemic transformation than those with low SETBP1 expression (Fig. 5C, D). The gene discussed is SETBP1; the disease is myelodysplastic syndrome.